幼年型肌炎与狼疮皮损的基因表达比较:重叠但独特的病理生理
本研究对15例幼年型肌炎(9例皮损、6例非皮损)、5例儿童期起病SLE及8例对照的皮肤活检进行转录组分析,发现皮损幼年型肌炎以干扰素(IFN)信号为主导,与儿童期SLE皮损基因表达高度重叠但存在28个独特差异基因,且NXP-2抗体阳性患者IFN特征最强。
要点
- 皮损幼年型肌炎以I型IFN信号为核心,CXCL10、CXCL9、IFI44L为前三大差异基因。
- 与儿童期SLE皮损相比,仅28个独特差异基因,包括FBLN2、CHKA、SLURP1。
- NXP-2抗体阳性幼年型肌炎患者IFN评分最高,Mx-1免疫染色最广泛。
核心结论
- 皮损幼年型肌炎皮肤呈现显著的IFN特征,与肌肉和外周血报道相似,且与儿童期SLE皮损基因表达高度重叠但存在独特差异基因。
- NXP-2自身抗体阳性与更强的IFN特征相关,可能提示疾病内型。
研究设计与样本
- 研究采用福尔马林固定石蜡包埋皮肤活检样本,包括15例幼年型肌炎(9例皮损、6例非皮损)、5例儿童期起病SLE和8例对照。
- 进行转录组分析鉴定组间显著差异表达基因(DEGs;q ≤ 5%),并用Ingenuity Pathway Analysis(IPA)富集生物学通路,通过免疫组化和实时定量PCR验证。
主要发现
- 皮损幼年型肌炎与对照比较发现221个DEGs,多数上调基因为IFN刺激基因。
- CXCL10、CXCL9和IFI44L为前三大DEGs(倍数变化分别为23.2、13.3和13.0;q < 0.0001)。
- IPA显示IFN信号为最富集的经典通路。
- 与儿童期SLE皮损相比,幼年型肌炎皮损共享相似基因表达模式,仅28个独特DEGs,包括FBLN2、CHKA和SLURP1。
- NXP-2自身抗体阳性幼年型肌炎患者表现出最强的IFN特征,并在角质形成细胞和血管周围区域显示最广泛的Mx-1免疫染色。
关键数值与推荐
- 差异表达基因定义为q ≤ 5%。
- 皮损幼年型肌炎 vs 对照:221个DEGs;CXCL10倍数变化23.2,CXCL9为13.3,IFI44L为13.0,q < 0.0001。
- 皮损幼年型肌炎 vs 儿童期SLE:28个独特DEGs。
临床怎么用
- 皮肤活检转录组可揭示幼年型肌炎皮损的IFN主导特征,有助于理解皮肤炎症机制。
- NXP-2抗体阳性患者IFN特征更强,提示该抗体可能与疾病内型相关,需进一步研究。
- 幼年型肌炎与儿童期SLE皮损基因表达高度重叠,提示两者皮肤炎症通路相似但存在独特差异。
局限性
- 样本量较小(幼年型肌炎15例、SLE 5例、对照8例),结果需扩大样本验证。
- 研究为横断面设计,无法推断因果关系。
- 仅分析皮肤活检转录组,未涉及其他组织或功能实验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Skin inflammation heralds systemic disease in juvenile myositis, yet we lack an understanding of pathogenic mechanisms driving skin inflammation in this disease. We undertook this study to define cutaneous gene expression signatures in juvenile myositis and identify key genes and pathways that differentiate skin disease in juvenile myositis from childhood-onset systemic lupus erythematosus (SLE). METHODS: We used formalin-fixed paraffin-embedded skin biopsy samples from 15 patients with juvenile myositis (9 lesional, 6 nonlesional), 5 patients with childhood-onset SLE, and 8 controls to perform transcriptomic analysis and identify significantly differentially expressed genes (DEGs; q ≤ 5%) between patient groups. We used Ingenuity Pathway Analysis (IPA) to highlight enriched biologic pathways and validated DEGs by immunohistochemistry and quantitative real-time polymerase chain reaction. RESULTS: Comparison of lesional juvenile myositis to control samples revealed 221 DEGs, with the majority of up-regulated genes representing interferon (IFN)-stimulated genes. CXCL10, CXCL9, and IFI44L represented the top 3 DEGs (fold change 23.2, 13.3, and 13.0, respectively; q < 0.0001). IPA revealed IFN signaling as the top canonical pathway. When compared to childhood-onset SLE, lesional juvenile myositis skin shared a similar gene expression pattern, with only 28 unique DEGs, including FBLN2, CHKA, and SLURP1. Notably, patients with juvenile myositis who were positive for nuclear matrix protein 2 (NXP-2) autoantibodies exhibited the strongest IFN signature and also demonstrated the most extensive Mx-1 immunostaining, both in keratinocytes and perivascular regions. CONCLUSION: Lesional juvenile myositis skin demonstrates a striking IFN signature similar to that previously reported in juvenile myositis muscle and peripheral blood. Further investigation into the association of a higher IFN score with NXP-2 autoantibodies may provide insight into disease endotypes and pathogenesis.
引用
- Turnier JL, Pachman LM, Lowe L, et al. Comparison of Lesional Juvenile Myositis and Lupus Skin Reveals Overlapping Yet Unique Disease Pathophysiology. Arthritis Rheumatol. 2021. PMID: 33305541. doi:10.1002/art.41615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。